Jubilant Flame International, Ltd - Quarter Report: 2016 May (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 31, 2016
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 333-173456
Jubilant Flame International, LTD |
(Exact name of registrant as specified in its charter) |
Nevada
(State or other jurisdiction of incorporation or organization)
2293 Hong Qiao Rd., Shanghai, China 200336
(Address of principal executive offices, including zip code.)
+ 86 21 64748888
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-Y (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "small reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ¨ | Accelerated filer | ¨ |
Non-accelerated filer | ¨ | Smaller reporting company | x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x
As of July 11, 2016, there are 8,792,207 shares of common stock outstanding.
All references in this Report on Form 10-Q to the terms "we", "our", "us", the "Company" and the "Registrant" refer to Jubilant Flame International Ltd unless the context indicates another meaning.
JUBILANT FLAME INTERNATIONAL LTD
| Page |
| |||
|
|
|
| ||
|
|
| |||
|
|
|
|
|
|
Item 1. |
|
| 3 |
| |
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
| 12 |
|
Item 3. |
|
| 15 |
| |
Item 4. |
|
| 15 |
| |
|
|
|
|
| |
|
|
|
| ||
|
|
|
|
|
|
Item 1. |
|
| 16 |
| |
Item 1A. |
|
| 16 |
| |
Item 2. |
|
| 16 |
| |
Item 3. |
|
| 16 |
| |
Item 4. |
|
| 16 |
| |
Item 5. |
|
| 16 |
| |
Item 6. |
|
| 17 |
| |
|
| 18 |
|
2 |
PART I – FINANCIAL INFORMATION
JUBILANT FLAME INTERNATIONAL LTD
FOR THE THREE MONTH PERIOD ENDED MAY 31, 2016 AND 2015
Index to Unaudited Financial Statements
3 |
Balance Sheets | ||||||||||||||||||||||
(Unaudited) |
|
| May 31, |
|
| February 29, |
| ||
|
| 2016 |
|
| 2016 |
| ||
ASSETS |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
Current assets |
|
|
|
|
|
| ||
Cash |
| $ | 313 |
|
| $ | 4,998 |
|
Prepaid expenses |
|
| 5,625 |
|
|
| 5,625 |
|
Total current assets |
|
| 5,938 |
|
|
| 10,623 |
|
|
|
|
|
|
|
|
|
|
Other assets |
|
|
|
|
|
|
|
|
Security deposit |
|
| 2,000 |
|
|
| 2,000 |
|
Website net of $6,944 and $4,861 of amortization, respectively |
|
| 18,056 |
|
|
| 20,139 |
|
Total other assets |
|
| 20,056 |
|
|
| 22,139 |
|
|
|
|
|
|
|
|
|
|
Total Assets |
| $ | 25,994 |
|
| $ | 32,762 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES & STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
| $ | 9,494 |
|
| $ | 9,494 |
|
Accrued officer compensation |
|
| 568,500 |
|
|
| 518,250 |
|
Loan payable - related parties |
|
| 235,840 |
|
|
| 224,473 |
|
Total current liabilities |
|
| 813,834 |
|
|
| 752,217 |
|
|
|
|
|
|
|
|
|
|
Convertible note net of debt discount of $48,814 |
|
| 11,186 |
|
|
| 6,315 |
|
Derivative liability |
|
| 83,768 |
|
|
| 83,049 |
|
|
|
|
|
|
|
|
|
|
Total Liabilities |
|
| 908,788 |
|
|
| 841,581 |
|
|
|
|
|
|
|
|
|
|
Stockholders' Deficit |
|
|
|
|
|
|
|
|
Common stock, $0.001 par value per share 75,000,000 shares authorized; 8,678,571 and 8,678,571 shares issued and outstanding respectively |
|
| 8,679 |
|
|
| 8,679 |
|
Additional paid in capital |
|
| 1,027,949 |
|
|
| 922,949 |
|
Accumulated deficit |
|
| (1,919,422 | ) |
|
| (1,740,447 | ) |
Total Stockholders' Deficit |
|
| (882,794 | ) |
|
| (808,819 | ) |
|
|
|
|
|
|
|
|
|
Total Liabilities and Stockholders' Deficit |
| $ | 25,994 |
|
| $ | 32,762 |
|
The accompanying notes are an integral part of the financial statements.
4 |
Statements of Operations | ||||||
(Unaudited) |
|
| Three Months |
|
| Three Months |
| ||
|
| Ended |
|
| Ended |
| ||
|
| May 31, |
|
| May 31, |
| ||
|
|
|
|
|
|
| ||
Operating Expenses: |
|
|
|
|
|
| ||
General and administrative |
| $ | 173,385 |
|
| $ | 51,037 |
|
Total operating expenses |
|
| 173,385 |
|
|
| 51,037 |
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
| (173,385 | ) |
|
| (51,037 | ) |
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
Change in derivatives liability |
|
| (719 | ) |
|
| - |
|
Debt discount amortization expense |
|
| (4,871 | ) |
|
| - |
|
Other income (expense) net |
|
| (5,590 | ) |
|
| - |
|
|
|
|
|
|
|
|
|
|
Net loss |
| $ | (178,975 | ) |
| $ | (51,037 | ) |
|
|
|
|
|
|
|
|
|
Net loss per share |
|
|
|
|
|
|
|
|
(Basic and fully diluted) |
|
|
|
|
|
|
|
|
Total operations |
| $ | (0.02 | ) |
| $ | (0.01 | ) |
|
|
|
|
|
|
|
| |
Weighted average number of common shares outstanding |
|
| 8,678,571 |
|
|
| 8,500,000 |
|
The accompanying notes are an integral part of the financial statements.
5 |
Statements of Cash Flows | ||||||||||
(Unaudited) |
|
| Three Months |
|
| Three Months |
| ||
|
| Ended |
|
| Ended |
| ||
|
| May 31, |
|
| May 31, |
| ||
Cash flows from operating activities |
|
|
|
|
|
| ||
Net loss |
| $ | (178,975 | ) |
| $ | (51,037 | ) |
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|
|
|
|
|
Website amortization |
|
| 2,083 |
|
|
| - |
|
Debt discount amortization |
|
| 4,871 |
|
|
|
|
|
Change in derivative liability |
|
| 719 |
|
|
|
|
|
Issuable stock compensation |
|
| 105,000 |
|
|
|
|
|
Changes in |
|
|
|
|
|
|
|
|
Accounts payable |
|
| - |
|
|
| 425 |
|
Accrued officer's compensation |
|
| 50,250 |
|
|
| 39,000 |
|
Net cash used in operating activities |
|
| (16,052 | ) |
|
| (11,612 | ) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Net proceed from related party loans |
|
| 11,367 |
|
|
| 11,612 |
|
|
|
|
|
|
|
|
|
|
Net Increase (Decrease) In Cash |
|
| (4,685 | ) |
|
| - |
|
Cash at beginning of period |
|
| 4,998 |
|
|
| 4,988 |
|
|
|
|
|
|
|
|
|
|
Cash at end of period |
| $ | 313 |
|
| $ | 4,988 |
|
|
|
|
|
|
|
|
|
|
Schedule of Non-Cash Investing and Financing Activities |
|
|
|
|
|
|
|
|
Cash paid for interest |
| $ | - |
|
| $ | - |
|
Cash paid for income taxes |
| $ | - |
|
| $ | - |
|
The accompanying notes are an integral part of the financial statements.
6 |
JUBILANT FLAME INTERNATIONAL, LTD
NOTES TO UNAUDITED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MAY 31, 2016 AND MAY 31, 2015
NOTE 1 – ORGANIZATION AND OPERATIONS
Jubilant Flame International, Ltd. (the "Company"), was formed on September 29, 2009 under the name Liberty Vision, Inc.
On November 16, 2015, the Company entered into the cosmetic sector by entering into a Distribution / License Agreement with Rubyfield Holdings LTD ("Rubyfield"), a company organized under the laws of Hong Kong, whereby the Company is Rubyfield's exclusive independent authorized Master Distributor for all of North America for certain products pertaining to the cosmetics industry. The Company's president, Ms. Yan Li, is also president of, and exercises control over Rubyfield.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Company's financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").
Interim Financial Information
Interim financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") as promulgated in Item 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of May 31, 2016, results of operations, changes in stockholders' equity (deficit) and cash flows for the three month periods ended May 31, 2016 and 2015, as applicable, have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Form 10-K.
7 |
Use of Estimates and Assumptions
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
The Company's significant estimates include income tax provisions and valuation allowances of deferred tax assets; the fair value of financial instruments and the assumption that the company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.
Net Loss Per Common Share
Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period.
NOTE 3 – GOING CONCERN
The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As at May 31, 2016 the Company had current assets of $5,938, and current liabilities total $813,834 resulting in a working capital deficit of $807,896. The Company currently has no profitable trading activities and has an accumulated deficit of $1,919,422 as at May 31, 2016. This raises substantial doubt about the Company's ability to continue as a going concern.
The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its new business plan in the medical and cosmetics sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.
8 |
NOTE 4 – CONVERTIBLE DEBT
On December 9, 2016, the Company issued convertible promissory notes totaling $60,000. At the time of issuance, the notes were evaluated and were determined to contain embedded conversion options that must be bifurcated and reported at fair value with original issue discounts. As a result, a derivative discount on convertible promissory notes was recorded, which net of discount amortization for the three months ended May 31, 2016 amounted to $9,212.
Description |
| 31-May- |
|
| 31-May- |
| ||
One convertible promissory note in amount of $60,000, with maturity date of December 9, 2018, bearing interest 0% per annum, convertible into common stock at conversion prices of 60% of the lowest price in the prior 20 trading days. The Company expects all debt will be converted to common shares. |
| $ | 60,000 |
|
| $ | - |
|
Less: debt discount |
|
| (58,026 | ) |
|
| - |
|
Less: conversions |
|
| - |
|
|
| - |
|
Add: amortization of debt discount |
|
| 9,212 |
|
|
| - |
|
Balance of convertible debt, net |
|
| 11,186 |
|
|
| - |
|
Less: current portion |
|
| - |
|
|
| - |
|
Long-term convertible debt, net |
| $ | 11,186 |
|
| $ | - |
|
Debt Discount
By the three months ended May 31, 2016, the Company has recorded debt discounts totaling $58,026.
The Company amortized total debt discount of $9,212 by the three months ended May 31, 2016.
Debt discount consisted of the following at May 31, 2016:
|
| May 31, |
| |
|
|
|
| |
Debt discount |
| $ | 58,026 |
|
Accumulated amortization of debt discount |
|
| (9,212 | ) |
Debt discount - net |
| $ | 48,814 |
|
9 |
Derivative Liabilities
The Company identified the conversion features embedded within its convertible debts as financial derivatives. The Company has determined that the embedded conversion option should be accounted for at fair value.
The following schedule shows the change in fair value of the derivative liabilities during the three months ended May 31, 2016:
Derivative liabilities - February 29, 2016 |
| $ | 83,049 |
|
Add fair value at the commitment date for convertible notes issued during the current quarter |
|
| - |
|
Fair value mark to market adjustment for derivatives |
|
| 719 |
|
Derivative liabilities - May 31, 2016 |
|
| 83,768 |
|
Less: current portion |
|
| - |
|
Long-term derivative liabilities |
| $ | 83,768 |
|
The Company recorded the debt discount to the extent of the gross proceeds raised, and expensed immediately the remaining value of the derivative as it exceeded the gross proceeds of the note. The Company recorded derivative interest expenses for the three months ended May 31, 2016 of 0 and change in derivatives liability of $719.
The fair value at the commitment and re-measurement dates for the Company's derivative liabilities were based upon the following management assumptions during the year:
Assumption |
| Commitment Date |
|
| Re-measurement Date |
| ||
Expected dividends: |
|
| 0 | % |
|
| 0 | % |
Expected volatility: |
|
| 45 | % |
|
| 79.39 | % |
Expected term (years): |
|
| 3 |
|
|
| 2.52 |
|
Risk free interest rate: |
|
| 1.22 | % |
|
| 1.03 | % |
10 |
NOTE 5 – RELATED PARTY TRANSACTIONS
In support of the Company's efforts and cash requirements, it must rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. The advances are considered temporary in nature and have not been formalized by a promissory note.
As at May 31, 2016, the Company had a $228,000 loan outstanding with the shareholder of the Company and a loan of $7,840 with the treasurer and secretary of the Company. This compares with the outstanding balance of $216,474 for the shareholder and $8,000 for the treasurer at February 29, 2016. The loans are non-interest bearing, due upon demand and unsecured.
NOTE 6 – ACCRUED OFFICER COMPENSATION
As at May 31, 2016, a total of $568,500 had been accrued as compensation payable to the two officers compared to $518,250 at February 29, 2016.
NOTE 7 – SUBSEQUENT EVENTS
In accordance with ASC 855-10, "Subsequent Events", the Company has analyzed its operations subsequent to May 31, 2016 to July 14, 2016, the date when the financial statements were issued. The Management of the Company determined that there were no reportable events that occurred during that subsequent period to be disclosed or recorded except following:
On June 30, 2016, a holder of the Company's convertible debt elected to convert a portion of that debt into 113,636 shares of the Company's common stock.
11 |
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.
Our Business
Jubilant Flame International, Ltd., (the "Company", "the "Registrant", "we", "us" or "our") was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from "LBYV" to "JFIL." On July 24, 2013, the Company changed its business sector to the medical sector. On September 30, 2013, the Company entered into a world-wide five year licensing agreement with BioMark Technologies (Asia) Limited ("BioMark") whereby the Company is licensed to sell, market, and, or, distribute certain products pertaining to the health care industry; and to conduct research and development of BioMark's cancer detection scanning technology. On May 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.
The Company develops and plans to market medical products under license from BioMark. The licensed products include Bone-Induction Artificial Bone ("BIAB") products and Vacuum Sealing Drainage ("VSD") products. The Company is also licensed to conduct research and development of BioMark's cancer detection scanning technology. In the event that the research and development of BioMark's cancer detection scanning technology provides marketable technology, the Company shall have the right of first refusal to a license to market, sell and distribute such cancer detection scanning technology.
Results of Operations
For the three months ended May 31, 2016 compared to the three months ended May 31, 2015
Revenue
We recognized no revenue in the three months ended May 31, 2016 and 2015 as we have not commenced operations as yet.
12 |
Operating Expenses
The major components of our operating expenses for the three months ended May 31, 2016 and 2015 are outlined in the table below:
|
| Three Months Ended |
|
| Three Months Ended |
| ||
|
| May 31 |
|
| May 31 |
| ||
|
| 2016 |
|
| 2015 |
| ||
|
|
|
|
|
|
| ||
Officer compensation |
| $ | 155,250 |
|
| $ | 39,000 |
|
Professional fees |
| $ | 8,259 |
|
| $ | 12,037 |
|
Rent |
| $ | 6,000 |
|
|
|
|
|
Web amortization expense |
| $ | 2,083 |
|
|
|
|
|
Office expense and other |
| $ | 1,792 |
|
|
|
|
|
Total operating expenses |
| $ | 173,385 |
|
| $ | 51,037 |
|
The $122,348 increase in our operating costs for the three months ended May 31, 2016 compared to three months ended May 31, 2015, was mainly due to the $116,250 increase in officers' compensation, $6,000 increase in rent, $2,083 increase in website amortization. The increases were partially offset by $3,778 decrease in professional fees.
Other Expenses
Other expenses increased to $5,590 for the three months ended May 31, 2016, from $0 for the three months ended May 31, 2015. Other expenses consisted primarily of $4,871 debt discount amortization expense and $719 of change in derivatives liability. The debt discount amortization and interest expense increase is due to a convertible promissory note issued on December 9, 2015.
Net Loss
For the three months ended May 31, 2016, we recognized a net loss of $178,975 compared to the net loss of $51,037 for the corresponding period in 2015.
Liquidity and Capital Resources
Working Capital
|
| May 31, |
|
| February 29, |
| ||
Current Assets |
| $ | 5,938 |
|
| $ | 10,623 |
|
Current Liabilities |
| $ | 813,834 |
|
| $ | 752,217 |
|
Working Capital Deficit |
| $ | (807,896 | ) |
| $ | (741,594 | ) |
13 |
As at May 31, 2016, the Company had current assets, comprising of cash of $313 and prepaid expenses of $5,625, and current liabilities of $813,834 resulting in a working capital deficit of $807,896. The Company currently has no profitable trading activities and has an accumulated deficit of $1,919,422 as at May 31, 2016. This raises substantial doubt about the Company's ability to continue as a going concern.
The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future
The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its new business plan in the medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.
Cash Flow for the three months ended May 31, 2016 compared to the three months ended May 31, 2015
The table below, for the periods indicated, provides selected cash flow information:
|
| Three months Ended May 31, |
|
| Three Months Ended May 31, |
| ||
Cash provided by (used in) operating activities |
| $ | (16,052 | ) |
| $ | (11,612 | ) |
Cash used in investing activities |
|
| 0 |
|
|
| 0 |
|
Cash provided by financing activities |
|
| 11,367 |
|
|
| 11,612 |
|
Net increase (decrease) in cash |
| $ | (4,685 | ) |
| $ | 0 |
|
Cash Flows from Operating Activities
Our net cash used in operating activities increased by $4,440 in the three months ended May 31, 2016 compared to that in the three months ended May 31, 2015, representing an increase of 38.2%. The increase in net cash used in operating activities was primarily the result of new rent expense of $6,000 during the three months ended May 31, 2016 as compared to $0 during the three months ended May 31, 2015.
Cash Flows from Investing Activities
We did not generate or use any cash from investing activities during the three months ended May 31, 2016 or 2015.
Cash Flows from Financing Activities
Our cash provided by financing activities decreased from $11,612 for the three months ended May 31, 2015 to $11,367 for the three months ended May 31, 2016. In both periods, cash was provided by way of loans from related parties.
14 |
Future Financings
We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.
Effective June 18, 2015, Jubilant Flame International, LTD (the "Company") entered into an Equity Purchase Agreement, and a Registration Rights Agreement (collectively the "Agreements") with Premier Venture Partners, LLC, a California limited liability company (the "Investor").
Pursuant to the terms of the Agreements, the Investor shall invest up to Five Million U.S. Dollars ($5,000,000) to purchase the Company's common stock in reliance upon the exemption from securities registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the "1933 Act"), Rule 506 of Regulation D promulgated by the SEC under the 1933 Act, and/or upon such other exemption from the registration requirements of the 1933 Act as may be available with respect to any or all of the sales of shares of the Common Stock made pursuant to the Agreements. The Company has further agreed to register the shares of common stock sold to the Investor pursuant to the 1933 Act, and the rules and regulations promulgated thereunder, and applicable state securities laws.
Recent Accounting Pronouncements
In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30) - Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 amends previous guidance to require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The standard is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted for financial statements that have not been previously issued. The Company adopted ASU No.2015-03 regarding the presentation of debt issuance cost since the year end of February 29, 2016.
The Company may pay debt issue costs and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are treated as debt discount and are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.
Off Balance Sheet Arrangements
As of May 31, 2016, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.
ITEM 4. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective. Our management reached the conclusion that our disclosure controls and procedures were not effective and as a result the filings for yearend were delayed. We are presently examining changes to our procedures and policies to ensure a more timing reporting.
15 |
We were not subject to any legal proceedings during the three months ended May 31, 2016 or 2015, respectively, and currently we are not involved in any pending litigation or legal proceedings.
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
No unregistered sales of equity were completed in the three months ended May 31, 2016 or 2015, respectively. On July 28, 2015, in consideration of the execution and delivery of the Equity Purchase Agreement by Premier Venture Partners, LLC, we issued 178,571 shares of our common stock to Premier Venture.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
No senior securities were issued and outstanding during the three months ended May 31, 2016 or 2015, respectively.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable to our Company.
In June, JFIL has commenced negotiations to lease a parcel of land in Canada that will house a Golf course and a wellness center. This will enable JFIL not only generate revenue immediately but will be a center to show all of our products in one location. Negotiations should be completed by the end of next quarter.
16 |
The following documents are filed as a part of this report:
EXHIBIT NUMBER | DESCRIPTION | |
01.INS ** | XBRL Instance Document | |
101.SCH ** | XBRL Taxonomy Extension Schema Document | |
101.CAL ** | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF ** | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB ** | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE ** | XBRL Taxonomy Extension Presentation Linkbase Document |
________________
** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
17 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
JUBILANT FLAME INTERNATIONAL LTD | |||
Date: July 14, 2016 | By: | /s/ Yan Li | |
|
| Yan Li | |
President and Director |
| 18 |